Wade Financial Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$247K Sell
1,489
-212
-12% -$33.2K 0.08% 69
2024
Q4
$246K Sell
1,701
-160
-9% -$24.8K 0.08% 71
2024
Q3
$302K Hold
1,861
0.1% 64
2024
Q2
$272K Hold
1,861
0.1% 67
2024
Q1
$294K Hold
1,861
0.11% 66
2023
Q4
$292K Sell
1,861
-373
-17% -$57.2K 0.11% 67
2023
Q3
$348K Buy
2,234
+148
+7% +$24.4K 0.15% 61
2023
Q2
$345K Sell
2,086
-127
-6% -$20.5K 0.14% 61
2023
Q1
$343K Hold
2,213
0.14% 61
2022
Q4
$391K Hold
2,213
0.18% 59
2022
Q3
$361K Hold
2,213
0.18% 60
2022
Q2
$393K Hold
2,213
0.19% 57
2022
Q1
$392K Buy
2,213
+915
+70% +$156K 0.17% 59
2021
Q4
$222K Buy
1,298
+1
+0.1% +$164 0.12% 71
2021
Q3
$209K Buy
+1,297
New +$221K 0.12% 73

Other funds holding JNJ

Wade Financial Advisory's JNJ Position: Q1 2025 in Review

Wade Financial Advisory reduced its Johnson & Johnson (JNJ) stake by 12% in Q1 2025, selling an estimated $33.2K and leaving 1,489 shares worth $247K. The position accounts for 0.08% of the portfolio, ranked #69.

Wade Financial Advisory first reported a position in JNJ in Q3 2021 and has held it in 15 quarters since. The position peaked at $393K in Q2 2022. 4,147 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Wade Financial Advisory held 1,489 shares of Johnson & Johnson worth $247K as of Q1 2025.
  • Wade Financial Advisory sold 212 Johnson & Johnson shares in Q1 2025, an estimated $33.2K.
  • Johnson & Johnson made up 0.08% of Wade Financial Advisory's portfolio in Q1 2025, its #69 holding.
  • Wade Financial Advisory first reported a position in Johnson & Johnson in Q3 2021 and has held it in 15 quarters since.
  • Wade Financial Advisory's Johnson & Johnson position peaked at $393K in Q2 2022.
  • 4,147 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Wade Financial Advisory's 13F filing for Q1 2025, filed 9 May 2025.